Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Texas Instruments reports Q3 results on October 19 with the Street broadly constructive but divided on whether last quarter's momentum can hold.
The options market is not raising alarm flags heading in. The put/call ratio of 0.77 is almost exactly in line with its 20-day average of 0.78, with a z-score near zero. That reads as neutral rather than defensive, a relatively calm setup for a stock that fell 2.2% the day after its last earnings release and then dropped a further 6.9% over the following five trading days. Short interest, at 2.2% of the free float, is low and not a meaningful signal in either direction. Borrow conditions are loose, with availability at the top of its range and cost to borrow just 0.32%, down about 8% on the week. Nothing in the lending market points to meaningful short-side conviction ahead of the print.
The real tension is in the fundamental debate. Bulls point to the Q2 print as evidence of durable recovery: revenue of $5.46B, up 23% year-on-year, gross margin at 61.4%, and EPS of $2.14, up 52%. TXN's manufacturing footprint and shorter lead times than competitors are cited as structural advantages that support further margin expansion. Bears push back on the durability question. Market share pressure in Analog and Embedded, which together account for roughly 90% of revenue, remains a concern, and some on the Street question whether the Q2 beat was a genuine demand inflection or inventory normalisation dressed up as growth. Morgan Stanley holds an Underweight with a $255 target, the most sceptical call in a pack that mostly lifted targets after the July print. JPMorgan sits at the opposite end, raising its target to $340 with an Overweight rating. The consensus sits at $324.71 against a current price of $276.48, though all of these target revisions came in late July and the consensus has not been updated since late August, so it predates any data from the current quarter.
Retail attention to TXN has ticked up meaningfully, with Wikipedia page views running at a z-score of 1.93 against the company's own prior 90 days. That is an attention signal, not a revenue or sentiment indicator, but it does suggest the name is drawing more eyes than usual in the run-up to the report.
Peer moves this week add a note of caution. STMPA and IFX both fell sharply, down 13.7% and 10.9% respectively over the week, suggesting European analog players are absorbing fresh macro pressure. MCHP and NXPI posted single-day gains of around 4.6%, pointing to a less uniform picture across the peer group. The print will test whether TXN's recovery narrative can survive a still-uncertain industrial end market or whether the Q2 numbers were the high-water mark for this cycle.
See the live data behind this article on ORTEX.
Open TXN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
